Tjarks, B Joel <br/><br/>
Scleroderma-like skin changes induced by checkpoint inhibitor therapy.  [electronic resource] 

 -  Journal of cutaneous pathology  Aug 2018 
 - 615-618 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1600-0560 
<br/><br/><label>Standard No.: </label>10.1111/cup.13273  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Carcinoma, Renal Cell--drug therapy<br/>Humans<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Nivolumab<br/>Scleroderma, Localized--chemically induced